Treating neuroleptic malignant syndrome as catatonia.
Fink
M
M
D002389:Catatonia / Q000188:drug therapy*; D003620:Dantrolene / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000627:therapeutic use*; D006801:Humans; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy*
D018491:Dopamine Agonists; D009125:Muscle Relaxants, Central; D003620:Dantrolene